Insulin aspart, recombinant Subcutaneous and Ravicti Oral Liquid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ravicti Oral Liquid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: Ravicti
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rayaldee
- Insulin aspart, recombinant Subcutaneous-Rayos
- Insulin aspart, recombinant Subcutaneous-Razadyne
- Insulin aspart, recombinant Subcutaneous-Razadyne (Galantamine Solution)
- Insulin aspart, recombinant Subcutaneous-Razadyne (Galantamine Tablets)
- Insulin aspart, recombinant Subcutaneous-Razadyne ER
- Ravicti Oral Liquid-Insulin degludec
- Ravicti Oral Liquid-Insulin Degludec (U-100) Prefilled Pens
- Ravicti Oral Liquid-Insulin Degludec (U-100) Vials
- Ravicti Oral Liquid-Insulin Degludec (U-200) Prefilled Pens
- Ravicti Oral Liquid-Insulin degludec and liraglutide
- Ravicti Oral Liquid-Insulin degludec and liraglutide Subcutaneous